Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Malone

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Economic Evaluation of Paclitaxel Albumin, Paclitaxel, and Docetaxel as a Second Line Treatment for Metastatic Breast CancerM Gharaibeh, D C Malone
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Economic burden of asthma: implications for outcomes and cost-effectiveness analysesD C Malone, E P Armstrong
Respiratory Medicine|December 20, 2003
Hydrofluoroalkane-134a beclomethasone as a dominant economic asthma therapyD C Malone, A T Luskin
Clinical Therapeutics|July 9, 1999
Treatment of urge incontinence in Veterans Affairs medical centersD C Malone, G J Okano
The Annals of Pharmacotherapy|October 26, 2001
Adherence to ATS guidelines for hospitalized patients with community-acquired pneumoniaD C Malone, H M Shaban
Clinical Pharmacology and Therapeutics|November 6, 2009
Comparison of critical drug-drug interaction listings: the Department of Veterans Affairs medical system and standard reference compendiaE L Olvey, S Clauschee, D C Malone
American Pharmacy|March 1, 1993
Consumers' evaluation of value-added pharmacy servicesD C Malone, K L Rascati, J P Gagnon
Pharmacy Practice Management Quarterly|August 18, 2000
Asthma: an analysis of high-cost patientsD C Malone, K A Lawson, D H Smith
Archives of Family Medicine|August 6, 2000
Costs of beta-lactam allergies: selection and costs of antibiotics for patients with a reported beta-lactam allergyE J MacLaughlin, J J Saseen, D C Malone
Pharmacotherapy|August 12, 2000
The relationship between drug therapy noncompliance and patient characteristics, health-related quality of life, and health care costsS J Billups, D C Malone, B L Carter
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Economic Evaluation of Paclitaxel Albumin, Paclitaxel, and Docetaxel as a Second Line Treatment for Metastatic Breast CancerM Gharaibeh, D C Malone
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Economic burden of asthma: implications for outcomes and cost-effectiveness analysesD C Malone, E P Armstrong
Respiratory Medicine|December 20, 2003
Hydrofluoroalkane-134a beclomethasone as a dominant economic asthma therapyD C Malone, A T Luskin
Clinical Therapeutics|July 9, 1999
Treatment of urge incontinence in Veterans Affairs medical centersD C Malone, G J Okano
The Annals of Pharmacotherapy|October 26, 2001
Adherence to ATS guidelines for hospitalized patients with community-acquired pneumoniaD C Malone, H M Shaban
Clinical Pharmacology and Therapeutics|November 6, 2009
Comparison of critical drug-drug interaction listings: the Department of Veterans Affairs medical system and standard reference compendiaE L Olvey, S Clauschee, D C Malone
American Pharmacy|March 1, 1993
Consumers' evaluation of value-added pharmacy servicesD C Malone, K L Rascati, J P Gagnon
Pharmacy Practice Management Quarterly|August 18, 2000
Asthma: an analysis of high-cost patientsD C Malone, K A Lawson, D H Smith
Archives of Family Medicine|August 6, 2000
Costs of beta-lactam allergies: selection and costs of antibiotics for patients with a reported beta-lactam allergyE J MacLaughlin, J J Saseen, D C Malone
Pharmacotherapy|August 12, 2000
The relationship between drug therapy noncompliance and patient characteristics, health-related quality of life, and health care costsS J Billups, D C Malone, B L Carter
Pageof 4